Biocon Limited will hold a board meeting on Wednesday, November 04, 2026, to approve and record the unaudited standalone and consolidated financial results for the quarter and half year ended September 30, 2026, according to a regulatory filing. The company will also host an earnings conference call for analysts and investors on the same day at 4:00 p.m. IST via Zoom, with recordings and transcripts to be made available on its website. Trading window for the company's securities will be closed from October 01, 2026, to November 06, 2026.